<unk>  (pronounced ), sold under the trade name Zevalin, is a monoclonal antibody radioimmunotherapy treatment for non-Hodgkin's lymphoma. The drug uses the monoclonal mouse IgG1 antibody<unk>  in conjunction with the chelator<unk> , to which a radioactive isotope (either yttrium-90 or indium-111) is added.<unk>  is a modified version of DTPA whose carbon backbone contains an isothiocyanatobenzyl and a methyl group.
Ibritumomab tiuxetan
Tositumomab
Loncastuximab tesirine
Axitinib
Fostamatinib
Tucatinib
Neratinib
Dasatinib